vimarsana.com
Home
Live Updates
ABIONYX Pharma Announces New Positive Results in a Uveitis M
ABIONYX Pharma Announces New Positive Results in a Uveitis M
ABIONYX Pharma Announces New Positive Results in a Uveitis Model for the Strategic Development of the First Class of Biomedicines in Ophthalmology Based on its Recombinant apoA-I
ABIONYX Pharma announced new positive results in ophthalmology for the first class of CER-001-based biomedicines for the treatment of ocular pathologies, and the appointment of Mr. Jérôme Martinez...
Related Keywords
,
Senior Advisor ,
Temporary Authorization ,
Markets ,